Description
Saxenda® is a prescription medication containing liraglutide, a GLP-1 receptor agonist. It is approved for weight management in:
PMC
Adults with a body mass index (BMI) of 27 or higher who also have weight-related medical problems, or a BMI of 30 or higher.
Children aged 12–17 years with a body weight above 60 kg (132 lbs) and obesity.
💉 How to Use Saxenda®
Administration: Inject subcutaneously (under the skin) into the abdomen, thigh, or upper arm.
Timing: Once daily, at any time of day, independent of meals.
Starting Dose: 0.6 mg daily for one week.
Titration Schedule:
Week 1: 0.6 mg daily
Week 2: 1.2 mg daily
Week 3: 1.8 mg daily
Week 4: 2.4 mg daily
Week 5 and onward: 3.0 mg daily
This gradual increase helps minimize side effects
Reviews
There are no reviews yet.